BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 24598218)

  • 1. Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.
    Nozaki Y; Kinoshita K; Yano T; Shiga T; Hino S; Niki K; Kishimoto K; Funauchi M; Matsumura I
    Lupus; 2014 Jul; 23(8):769-77. PubMed ID: 24598218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U-KIM-1 as a predictor of treatment response in lupus nephritis.
    Nozaki Y; Shiga T; Ashida C; Tomita D; Itami T; Kishimoto K; Kinoshita K; Matsumura I
    Lupus; 2023 Jan; 32(1):54-62. PubMed ID: 36305170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
    Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH
    Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC; Zhang JJ; Chen M; Lv JC; Liu G; Zou WZ; Zhang H; Zhao MH
    Nephrol Dial Transplant; 2011 Oct; 26(10):3229-36. PubMed ID: 21402675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
    Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
    Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary sCD25 as a biomarker of lupus nephritis disease activity.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Lupus; 2015 Mar; 24(3):273-9. PubMed ID: 25305215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Injury Molecule-1 Level is Associated with the Severity of Renal Interstitial Injury and Prognosis in Adult Henoch-Schönlein Purpura Nephritis.
    Zhang Y; Li A; Wen J; Zhen J; Hao Q; Zhang Y; Hu Z; Xiao X
    Arch Med Res; 2017 Jul; 48(5):449-458. PubMed ID: 29122357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis.
    Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A
    Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubular kidney injury molecule-1 (KIM-1) in human renal disease.
    van Timmeren MM; van den Heuvel MC; Bailly V; Bakker SJ; van Goor H; Stegeman CA
    J Pathol; 2007 Jun; 212(2):209-17. PubMed ID: 17471468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy.
    Nogare AL; Veronese FV; Carpio VN; Montenegro RM; Pedroso JA; Pegas KL; Gonçalves LF; Manfro RC
    BMC Nephrol; 2015 Feb; 16():19. PubMed ID: 25884518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
    Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
    Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury.
    Zhang PL; Rothblum LI; Han WK; Blasick TM; Potdar S; Bonventre JV
    Kidney Int; 2008 Mar; 73(5):608-14. PubMed ID: 18160964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Clin Exp Rheumatol; 2015; 33(5):694-8. PubMed ID: 26211517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
    Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O
    BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.